What is a fossa ovalis membrane aneurysm (atrial septal aneurysm)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 16, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

What is a Fossa Ovalis Membrane Aneurysm (Atrial Septal Aneurysm)?

A fossa ovalis membrane aneurysm, also known as an atrial septal aneurysm (ASA), is an excessive bulging or redundant deformity of the interatrial septum, typically at the level of the fossa ovalis, that protrudes into the right atrium, left atrium, or both during the cardiac cycle. 1

Diagnostic Definition

The diagnosis is established when the interatrial septum demonstrates more than 10 mm excursion from the centerline during the cardiac cycle 2. More specifically:

  • Excursion threshold: The septum must bulge ≥10-15 mm from the plane of the atrial septum
  • Base diameter: At least 15 mm diameter base of the interatrial septum 3
  • Membrane characteristics: The fossa ovalis membrane is markedly enlarged (mean 711 mm² vs. 203 mm² in normal hearts) and significantly thinner (0.6 mm vs. 1.9 mm) 4

Anatomical Features

The aneurysm typically presents as:

  • Shape: Most commonly dome-shaped 5
  • Size: Excursion ranges from 10-35 mm (mean 16 mm), with width 16-40 mm (mean 24 mm) 5
  • Direction: Protrudes into the right atrium in 73% of cases, left atrium in 27% 5
  • Tissue quality: Characterized by thinning and marked redundancy of the fossa ovalis membrane 4

Prevalence

The frequency varies by detection method:

  • Transthoracic echocardiography: 1.9-2.5% in adults 2, 6
  • Transesophageal echocardiography: 2-10% in adults 7
  • Pediatric population: 0.9-1.7% in children, 4.9% in infants 7
  • General population: 2.4% in a large adult outpatient series 3

Clinical Significance and Associated Conditions

An atrial septal aneurysm is often associated with septal fenestrations and may be a marker of increased embolic risk 1. The clinical relevance stems from frequent associations with:

High-Risk Features:

  • Patent foramen ovale (PFO): Present in 70% of ASA cases vs. 20% in controls (p=0.0005) 4
  • Cryptogenic stroke: Higher prevalence in younger patients with unexplained stroke 2
  • Paradoxical embolism: The combination of ASA and PFO creates an anatomic substrate for right-to-left shunting of thrombus 2

Common Concurrent Pathologies:

  • Valvular regurgitation: 74% (mitral and aortic) 3, 6
  • Supraventricular arrhythmias: 16% 3
  • Mitral valve prolapse: 15% 6
  • Hypertension: 64% 6
  • Stroke: 20% 6

Diagnostic Approach

Transesophageal echocardiography has higher sensitivity for detection compared with transthoracic imaging and is recommended in younger adults with unexplained cerebrovascular events 1.

Detection Method:

  • Microbubbles enter the right atrium during saline contrast injection
  • If a PFO is present with ASA, bubbles pass into the left atrium within a few cardiac cycles
  • Valsalva maneuver increases sensitivity by transiently increasing right atrial pressure 1

Important Caveat:

Estimating PFO size based on contrast amount in the left atrium may be unreliable 1

Pathophysiology

The formation relates primarily to:

  • Abnormally elevated intracardiac pressures: In 91% of cases with patent foramen ovale 5
  • Congenital redundancy: Excessive tissue at the fossa ovalis 4
  • Bidirectional pressure changes: During cardiac cycle and respiration 1

Potential Complications

  • Paradoxical embolism: Via stretched patent foramen ovale allowing bidirectional shunting 5
  • Thrombus formation: Focal mural thrombus present on aneurysmal surface in some cases 5
  • Endocardial fibrosis: Present on the aneurysmal wall in several cases 5
  • Arrhythmias: Particularly supraventricular tachycardia 3, 8
  • Structural interference: Can narrow the inferior vena caval orifice in rare cases 5

Clinical Context for PFO Closure Planning

Transesophageal echocardiography is recommended for detailed visualization of atrial septal anatomy when PFO closure is planned 1. The presence of ASA may pose technical challenges during percutaneous closure procedures, though direct-suture techniques can effectively close the PFO and reduce aneurysmal redundancy 9.

Related Questions

If my echocardiogram shows an intra‑atrial septal aneurysm with a probable patent foramen ovale, should I see a cardiologist?
What is the significance of a highly mobile atrial septal aneurysm?
Does an atrial septal (fossa‑oval) aneurysm contribute to atrial flutter?
What is the appropriate evaluation and management for a patient whose echocardiogram shows a possible interatrial septal aneurysm and asymmetric basal septal hypertrophy?
What is the management for a patient with aneurysm (an abnormal dilation) of the atrial septum with a left to right shunt?
Should a patient with a bleeding peptic ulcer avoid hot drinks?
What is the recommended approach to screen for and manage postpartum depression, including first-line pharmacologic options compatible with breastfeeding and psychotherapy?
Can beta‑blockers be administered to a patient with non‑sustained ventricular tachycardia who is hemodynamically stable?
What is a carotid web, how is it diagnosed, and what are the recommended treatment options?
What is the recommended postoperative medication regimen for a patient after a ball joint hip replacement?
Given a right upper quadrant abdominal ultrasound showing a normal liver with several hyperechoic solid lesions, the largest measuring 2.0 × 1.7 × 2.6 cm in the superior left lobe and lacking Doppler flow, and liver function tests that are within normal limits except for mildly elevated aspartate aminotransferase (57 U/L) and alanine aminotransferase (138 U/L), what are the recommended next steps?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.